Skip to content
14th June 2026

Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells to view poster via stem cell factor

1st March 2025

Dual Targeting of Mast Cells and TSLP with the Bispecific Antibody CDX-622

1st February 2025

Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622

1st May 2023

Dual Targeting of Mast Cells and TSLP with a Bispecific Antibody

Top